Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan
· Delayed Price · Currency is TWD 16.30
+0.10 (0.62%)
Feb 21, 2025, 1:57 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 6.87 billion as of February 21, 2025. Its market cap has decreased by -9.78% in one year.
Market Cap
6.87B
Enterprise Value
6.64B
Revenue
5.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.30
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 6.87B, an increase of 34.55%. That is a compound annual growth rate of 14.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 6.87B | 24.90% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 209.72B |
| Caliway Biopharmaceuticals | 145.92B |
| Bora Pharmaceuticals Co., LTD. | 89.70B |
| Lotus Pharmaceutical | 72.59B |
| Lumosa Therapeutics | 39.86B |
| Oneness Biotech | 38.77B |
| Polaris Group | 36.08B |
| Pegavision | 30.30B |